Page 5 - ஐரோப்பிய கூட்டணி க்கு தனிப்பயனாக்கப்பட்டது மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EU Reporter Published 24 seconds ago Welcome, health colleagues, to the European Alliance for Personalised Medicine (EAPM) update – there is controversy afoot concerning access to new medicines across Europe, doubts expressed over sufficiency of COVID testing alone for foreign travel, and the end of the Medical Device Regulation’s transition period, writes EAPM Executive Director Dr. Denis Horgan. Stark divide on access to new medicines globally and in Europe The coronavirus pandemic is far from over, WHO Director-General Tedros Adhanom Ghebreyesus stressed this week, as he lamented new variants, vaccines shortages, and a global disparity in access to inoculations. There is a huge disconnect growing, where in some countries with the highest vaccination rates, there appears to be a mindset that the pandemic is over, while others are experiencing huge waves of infection, Tedros said. He expressed further concern about areas experiencing a continued high number of COVID-

United statesDenis horganMedtech europeSerge bernasconiJuan fernandoTedros adhanom ghebreyesusAndrea amonJoe bidenEuropean councilWorld health assemblyNational immunisation advisory committee niacEuropean alliance for personalised medicineEuropean medicines agencyCivil liberties committeeEuropean centre for disease preventionEuropean alliance